T. O'reilly
发表
Martin R. Schneider,
J. Mestan,
F. Totzke,
2000
.
Bhabatosh Chaudhuri,
Doriano Fabbro,
Pascal Furet,
2002,
Pharmacology & therapeutics.
D. Fabbro,
P. Furet,
T. O'reilly,
2001,
Journal of the National Cancer Institute.
Joanne Chan,
J. Wood,
T. Roberts,
2006,
Nature chemical biology.
T. O'reilly,
O. Zak,
1993,
The Journal of antimicrobial chemotherapy.
Pascal Furet,
Guido Bold,
Giorgio Caravatti,
2001,
Medicinal research reviews.
J. Mestan,
D. Fabbro,
T. Meyer,
1999,
Pharmacology & therapeutics.
C. Schnell,
J. Wood,
N. Hynes,
2005,
Clinical Cancer Research.
T. O'reilly,
L. Urbán,
B. Kidd,
2002,
Pain.
H. Lane,
J. Brueggen,
T. O'reilly,
2010,
Cancer Chemotherapy and Pharmacology.
P. Campochiaro,
D. Fabbro,
T. Meyer,
2000,
Anti-cancer drug design.
H. Lane,
C. Schnell,
J. Brueggen,
2009
.
T. O'reilly,
A. Flörsheimer,
W. Blum,
2001,
Rapid communications in mass spectrometry : RCM.
H. Lane,
M. Šuša,
T. O'reilly,
2004,
Bone.
T. O'reilly,
B. Car,
B. Moser,
2000,
Infection and Immunity.
J. Brueggen,
T. O'reilly,
M. Wartmann,
2008,
Cancer Chemotherapy and Pharmacology.
H. Lane,
C. Schnell,
J. Brueggen,
2010,
Cancer Chemotherapy and Pharmacology.
T. O'reilly,
M. Pruschy,
Katarzyna J. Nytko,
2015,
Journal of the National Cancer Institute.
K. Altmann,
T. O'reilly,
M. Wartmann,
2000,
Biochimica et biophysica acta.
K. Altmann,
T. O'reilly,
F. Wenger,
2005,
The Prostate.
K. Altmann,
T. O'reilly,
M. Wartmann,
2004,
Progress in medicinal chemistry.
T. O'reilly,
M. Wartmann,
Dario Sterker,
2018,
Anti-cancer drugs.
H. Lane,
F. Natt,
Jonathan Hall,
2005
.
H. Lane,
P. Lassota,
T. O'reilly,
2011,
Anti-cancer drugs.
Shiuan Chen,
H. Lane,
T. O'reilly,
2005,
Clinical Cancer Research.
H. Lane,
F. Natt,
Jonathan Hall,
2004
.
P. Black,
E. Buchdunger,
J. Alberta,
2000,
Cancer research.
C. Schnell,
R. Cozens,
C. García-echeverría,
2008,
Cancer research.
T. O'reilly,
P. McSheehy,
P. Mcsheehy,
2010,
Translational oncology.
David M. Thomas,
J. Desai,
J. Monahan,
2010,
Clinical Cancer Research.
E. Billy,
C. Schnell,
J. Wood,
2006,
Cancer research.
J. Mestan,
F. Totzke,
G. Martiny-Baron,
2000,
Cancer research.
J. Wood,
E. Buchdunger,
T. O'reilly,
2002,
European journal of cancer.
Terence O'reilly,
Robert Cozens,
R. Cozens,
2006
.
David M. Thomas,
J. Desai,
J. Monahan,
2010
.
H. Lane,
F. Natt,
Jonathan Hall,
2005,
Cell.
H. Lane,
Sonja Tobler,
T. O'reilly,
2004,
Cancer Research.
J. Brueggen,
J. Wood,
C. Springer,
2003,
British Journal of Cancer.
H. Lane,
G. Martiny-Baron,
C. Schnell,
2005
.
H. Lane,
E. Raymond,
J. Kovarik,
2008,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Michael Stumm,
C. Schnell,
J. Wood,
2005,
Clinical Cancer Research.
R. Motzer,
H. Lane,
T. O'reilly,
2011,
Expert opinion on drug discovery.
H. Lane,
G. Martiny-Baron,
C. Schnell,
2009,
Clinical Cancer Research.
K. Altmann,
S. Ferretti,
E. Buchdunger,
2005,
Cancer Chemotherapy and Pharmacology.
A. Kaim,
G. V. von Schulthess,
T. O'reilly,
2003,
Radiology.
H. Lane,
T. O'reilly,
S. Zumstein-Mecker,
2004
.
H. Lane,
T. O'reilly,
M. Pruschy,
2011
.
A. Kaim,
G. V. von Schulthess,
T. O'reilly,
2002,
Radiology.
C. Schnell,
S. Ferretti,
T. O'reilly,
2005
.
K. Altmann,
T. O'reilly,
M. Wartmann,
2004
.
Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.
H. Lane,
S. Ametamey,
T. O'reilly,
2010,
Translational oncology.
T. O'reilly,
J. Mader,
1999
.
M. Šuša,
T. O'reilly,
A. Teti,
2006
.
T. Geiser,
M. Baggiolini,
T. O'reilly,
1994,
The Journal of biological chemistry.
J. Wood,
P. Furet,
P. Traxler,
2001,
Medicinal research reviews.
T. O'reilly,
O. Zak,
A. Littlewood-Evans,
1997,
Infection and immunity.
T. O'reilly,
U. Wagner,
M. Stumm,
2012,
American journal of clinical pathology.
H. Lane,
E. Raymond,
J. Kovarik,
2008,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
P. Furet,
R. Cozens,
N. Lydon,
2001
.